Terms: = Sarcomas AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Diagnosis
49 results:
1. H3F3A mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature.
Ratnagiri R; Uppin S
J Cancer Res Ther; 2023; 19(3):832-834. PubMed ID: 37470622
[TBL] [Abstract] [Full Text] [Related]
2. Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
Fanburg-Smith JC; Smith JD; Flemming DJ
Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
[TBL] [Abstract] [Full Text] [Related]
3. Molecular and immunohistochemical testing of bone tumours: review and update.
Kovacs SK; Manassaporn A; Nielsen GP; Hung YP
Histopathology; 2023 May; 82(6):794-811. PubMed ID: 36424903
[TBL] [Abstract] [Full Text] [Related]
4. Dramatic response to entrectinib in a patient with malignant peripheral nerve sheath tumor harboring novel SNRNP70-NTRK3 fusion gene.
Kobayashi H; Makise N; Shinozaki-Ushiku A; Zhang L; Ishibashi Y; Ikegami M; Tsuda Y; Kohsaka S; Ushiku T; Oda K; Miyagawa K; Aburatani H; Mano H; Tanaka S
Genes Chromosomes Cancer; 2023 Jan; 62(1):47-51. PubMed ID: 35906852
[TBL] [Abstract] [Full Text] [Related]
5. A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL.
Yang K; Wang J; Kanwar N; Villani A; Ajani O; Fleming A; Patil V; Mamatjan Y; Wei Q; Malkin D; Shlien A; Zadeh G; Provias J
Brain Tumor Pathol; 2022 Oct; 39(4):225-231. PubMed ID: 35668302
[TBL] [Abstract] [Full Text] [Related]
6. Lung metastases and subsequent malignant transformation of a fumarate hydratase -deficient uterine leiomyoma.
Ahvenainen T; Khamaiseh S; Alkodsi A; Mehine M; Nevala R; Äyräväinen A; Bützow R; Vahteristo P
Exp Mol Pathol; 2022 Jun; 126():104760. PubMed ID: 35367216
[TBL] [Abstract] [Full Text] [Related]
7. Histological and immunohistochemical features and genetic alterations in the malignant progression of giant cell tumor of bone: a possible association with TP53 mutation and loss of H3K27 trimethylation.
Ishihara S; Yamamoto H; Iwasaki T; Toda Y; Yamamoto T; Yoshimoto M; Ito Y; Susuki Y; Kawaguchi K; Kinoshita I; Yamada Y; Kohashi K; Fujiwara T; Setsu N; Endo M; Matsumoto Y; Kakuda Y; Nakashima Y; Oda Y
Mod Pathol; 2022 May; 35(5):640-648. PubMed ID: 34785767
[TBL] [Abstract] [Full Text] [Related]
8. Low-grade epilepsy-associated neuroepithelial tumours with a prominent oligodendroglioma-like component: The diagnostic challenges.
Métais A; Appay R; Pagès M; Gallardo C; Silva K; Siegfried A; Perbet R; Maurage CA; Scavarda D; Fina F; Uro-Coste E; Riffaud L; Colin C; Figarella-Branger D;
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12769. PubMed ID: 34551121
[TBL] [Abstract] [Full Text] [Related]
9. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.
Leinauer B; Wolf E; Werner M; Baumhoer D; Breining T; Luebke AM; Maas R; Schultheiß M; von Baer A; Sufi-Siavach A; Moritz C; Geißler S; Mellert K; Möller P; Barth TFE; Jundt G
Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114
[TBL] [Abstract] [Full Text] [Related]
10. Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings.
Khanna L; Prasad SR; Yedururi S; Parameswaran AM; Marcal LP; Sandrasegaran K; Tirumani SH; Menias CO; Katabathina VS
Radiographics; 2021; 41(3):876-894. PubMed ID: 33891523
[TBL] [Abstract] [Full Text] [Related]
11. Investigation of anticancer activities of STA-9090 (ganetespib) as a second generation HSP90 inhibitor in Saos-2 osteosarcoma cells.
Özgür A
J Chemother; 2021 Dec; 33(8):554-563. PubMed ID: 33794753
[TBL] [Abstract] [Full Text] [Related]
12. Neurofibrosarcoma Revisited: An Institutional Case Series of Uterine sarcomas Harboring Kinase-related Fusions With Report of a Novel fgfr1-TACC1 Fusion.
Devereaux KA; Weiel JJ; Mills AM; Kunder CA; Longacre TA
Am J Surg Pathol; 2021 May; 45(5):638-652. PubMed ID: 33481389
[TBL] [Abstract] [Full Text] [Related]
13. Digital Quantification of Ki-67 and PHH3 in the Classification of Uterine Smooth Muscle Tumors.
Cao CD; Rico-Castillo J; De Cotiis D; Richard SD; Rosenblum NG; Chan JSY
Int J Gynecol Pathol; 2021 Nov; 40(6):549-555. PubMed ID: 33323861
[TBL] [Abstract] [Full Text] [Related]
14. Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.
Shao H; Wang W; Song J; Tang G; Zhang X; Tang Z; Srivastava J; Shah B; Medeiros LJ; Zhang L
Leuk Res; 2020 Dec; 99():106460. PubMed ID: 33166908
[TBL] [Abstract] [Full Text] [Related]
15. Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experience.
Pondrom M; Bougeard G; Karanian M; Bonneau-Lagacherie J; Boulanger C; Boutroux H; Briandet C; Chevreau C; Corradini N; Coze C; Defachelles AS; Galmiche-Roland L; Orbach D; Piguet C; Scoazec JY; Vérité C; Willems M; Frebourg T; Minard V; Brugières L
Pediatr Blood Cancer; 2020 Sep; 67(9):e28486. PubMed ID: 32658383
[TBL] [Abstract] [Full Text] [Related]
16. Multiple primary tumors: a case report and review of the literature.
Zhao Z; Sun K; Yan T; Wei R; Guo W
BMC Musculoskelet Disord; 2020 Jun; 21(1):394. PubMed ID: 32571290
[TBL] [Abstract] [Full Text] [Related]
17. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
[TBL] [Abstract] [Full Text] [Related]
18. hsa_circ0021347 as a Potential Target Regulated by B7-H3 in Modulating the Malignant Characteristics of Osteosarcoma.
Wang L; Zhang GC; Kang FB; Zhang L; Zhang YZ
Biomed Res Int; 2019; 2019():9301989. PubMed ID: 31950059
[TBL] [Abstract] [Full Text] [Related]
19. Giant cell tumor of soft tissue of the breast: Case report with H3F3A mutation analysis and review of the literature.
Luangxay T; Osako T; Yonekura R; Sugiura Y; Kikuchi M; Gomi N; Ueno T; Ohno S; Machinami R; Takeuchi K; Akiyama F
Pathol Res Pract; 2020 Feb; 216(2):152750. PubMed ID: 31784095
[TBL] [Abstract] [Full Text] [Related]
20. miR24-2 Promotes Malignant Progression of Human Liver Cancer Stem Cells by Enhancing Tyrosine Kinase Src Epigenetically.
Wang L; Li X; Zhang W; Yang Y; Meng Q; Wang C; Xin X; Jiang X; Song S; Lu Y; Pu H; Gui X; Li T; Xu J; Li J; Jia S; Lu D
Mol Ther; 2020 Feb; 28(2):572-586. PubMed ID: 31732298
[TBL] [Abstract] [Full Text] [Related]
[Next]